{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T01:03:34Z","timestamp":1789866214300,"version":"4.0.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,1,11]],"date-time":"2008-01-11T00:00:00Z","timestamp":1200009600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2008,1,11]],"date-time":"2008-01-11T00:00:00Z","timestamp":1200009600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Bisphosphonates have become standard therapy for the treatment of skeletal complications related to breast cancer. Although their therapeutic effects mainly result from an inhibition of osteoclastic bone resorption, <jats:italic>in vitro<\/jats:italic> data indicate that they also act directly on breast cancer cells, inhibiting proliferation and inducing apoptosis.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>The present study examined the effects of calcium (from 0.6 to 2.0 mmol\/l) on the antitumour activity of the bisphosphonate ibandronate (1 to 1,000 nmol\/l) on MDA-MB-231 and MCF-7 breast cancer cells. Cell culture densities were determined using crystal violet staining assay. Apoptotic cell death was assessed by annexin V-phycoerythrin and 7-amino-actinomycin double staining.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>At low calcium concentration, 30 \u03bcmol\/l ibandronate had no effect on MDA-MB-231 cells growth and only slightly inhibited MCF-7 cells growth. Higher calcium levels significantly increased growth inhibition as well as cell apoptosis induced by ibandronate. We observed similar effects with zoledronic acid. Of note, enhancement of ibandronate-induced growth inhibition was also observed in other breast cancer cell lines (T-47D, ZR-75, Hs-578T and BT-549 cells). The growth inhibitory effect of ibandronate in the presence of high concentrations of calcium was partly suppressed by the calcium chelator EGTA (ethylene glycol tetra-acetic acid). In addition, in the presence of calcium at high concentrations, cells accumulated more [<jats:sup>14<\/jats:sup>C]ibandronate than at low calcium concentrations. We obtained further evidence of enhancement of cellular ibandronate accumulation by calcium by demonstrating that high calcium levels increased the inhibition of protein prenylation induced by the bisphosphonate.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusion<\/jats:title>\n                        <jats:p>Altogether, our data suggest that extracellular calcium, probably through its binding to ibandronate, markedly increased its cellular accumulation and its inhibitory activity on breast tumour cells. Thus, calcium released during the process of tumour-induced osteolysis might enhance the antitumour effects of bisphosphonates and contribute to their therapeutic efficacy.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/bcr1845","type":"journal-article","created":{"date-parts":[[2008,1,11]],"date-time":"2008-01-11T19:13:32Z","timestamp":1200078812000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Extracellular calcium increases bisphosphonate-induced growth inhibition of breast cancer cells"],"prefix":"10.1186","volume":"10","author":[{"given":"Fabrice","family":"Journ\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na\u00efma","family":"Kheddoumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Chaboteaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugues","family":"Duvillier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Jacques","family":"Body","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,1,11]]},"reference":[{"key":"1809_CR1","volume-title":"Tumor Bone Diseases and Osteoporosis in Cancer Patients","author":"JJ Body","year":"2000","unstructured":"Body JJ: Tumor Bone Diseases and Osteoporosis in Cancer Patients. 2000, New York, NY; Marcel Dekker"},{"key":"1809_CR2","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1002\/jbmr.5650101008","volume":"10","author":"DE Hughes","year":"1995","unstructured":"Hughes DE, Wright KR, Uy HL, Sasaki A, Yoneda T, Roodman GD, Mundy GR, Boyce BF: Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res. 1995, 10: 1478-1487.","journal-title":"J Bone Miner Res"},{"key":"1809_CR3","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1359\/jbmr.1999.14.12.2048","volume":"14","author":"S Derenne","year":"1999","unstructured":"Derenne S, Amiot M, Barille S, Collette M, Robillard N, Berthaud P, Harousseau JL, Bataille R: Zoledronate is a potent inhibitor of myeloma cell growth and secretion of IL-6 and MMP-1 by the tumoral environment. J Bone Miner Res. 1999, 14: 2048-2056. 10.1359\/jbmr.1999.14.12.2048.","journal-title":"J Bone Miner Res"},{"key":"1809_CR4","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1359\/jbmr.2000.15.11.2211","volume":"15","author":"O Fromigue","year":"2000","unstructured":"Fromigue O, Lagneaux L, Body JJ: Bisphosphonates induce breast cancer cell death in vitro. J Bone Miner Res. 2000, 15: 2211-2221. 10.1359\/jbmr.2000.15.11.2211.","journal-title":"J Bone Miner Res"},{"key":"1809_CR5","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1054\/bjoc.1999.1131","volume":"82","author":"SG Senaratne","year":"2000","unstructured":"Senaratne SG, Pirianov G, Mansi JL, Arnett TR, Colston KW: Bisphosphonates induce apoptosis in human breast cancer cell lines. Br J Cancer. 2000, 82: 1459-1468.","journal-title":"Br J Cancer"},{"key":"1809_CR6","first-page":"4418","volume":"61","author":"T Hiraga","year":"2001","unstructured":"Hiraga T, Williams PJ, Mundy GR, Yoneda T: The bisphosphonate ibandronate promotes apoptosis in MDA-MB-231 human breast cancer cells in bone metastases. Cancer Res. 2001, 61: 4418-4424.","journal-title":"Cancer Res"},{"key":"1809_CR7","doi-asserted-by":"publisher","first-page":"R2","DOI":"10.1186\/bcr1363","volume":"8","author":"F Journe","year":"2006","unstructured":"Journe F, Chaboteaux C, Magne N, Duvillier H, Laurent G, Body JJ: Additive growth inhibitory effects of ibandronate and antiestrogens in estrogen receptor-positive breast cancer cell lines. Breast Cancer Res. 2006, 8: R2-10.1186\/bcr1363.","journal-title":"Breast Cancer Res"},{"key":"1809_CR8","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1093\/jnci\/djk054","volume":"99","author":"F Daubine","year":"2007","unstructured":"Daubine F, Le Gall C, Gasser J, Green J, Clezardin P: Antitumor effects of clinical dosing regimens of bisphosphonates in experimental breast cancer bone metastasis. J Natl Cancer Inst. 2007, 99: 322-330. 10.1093\/jnci\/djk054.","journal-title":"J Natl Cancer Inst"},{"key":"1809_CR9","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/sj.bjc.6601009","volume":"89","author":"O Fromigue","year":"2003","unstructured":"Fromigue O, Kheddoumi N, Body JJ: Bisphosphonates antagonise bone growth factors' effects on human breast cancer cells survival. Br J Cancer. 2003, 89: 178-184. 10.1038\/sj.bjc.6601009.","journal-title":"Br J Cancer"},{"key":"1809_CR10","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0378-5173(84)90089-9","volume":"21","author":"ML Lamson","year":"1984","unstructured":"Lamson ML, Fox JL, Huguchi WI: Calcium and 1-hydroxyethylidene-1,1-bisphosphonic acid: polynuclear complex formation in the physiological range of pH. Int J Pharm. 1984, 21: 143-154. 10.1016\/0378-5173(84)90089-9.","journal-title":"Int J Pharm"},{"key":"1809_CR11","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/8756-3282(96)00182-2","volume":"19","author":"P Masarachia","year":"1996","unstructured":"Masarachia P, Weinreb M, Balena R, Rodan GA: Comparison of the distribution of 3H-alendronate and 3H-etidronate in rat and mouse bones. Bone. 1996, 19: 281-290. 10.1016\/8756-3282(96)00182-2.","journal-title":"Bone"},{"key":"1809_CR12","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1124\/mol.105.020776","volume":"69","author":"K Thompson","year":"2006","unstructured":"Thompson K, Rogers MJ, Coxon FP, Crockett JC: Cytosolic entry of bisphosphonate drugs requires acidification of vesicles after fluid-phase endocytosis. Mol Pharmacol. 2006, 69: 1624-1632. 10.1124\/mol.105.020776.","journal-title":"Mol Pharmacol"},{"key":"1809_CR13","doi-asserted-by":"publisher","first-page":"8526","DOI":"10.1074\/jbc.C300511200","volume":"279","author":"DJ Hosfield","year":"2004","unstructured":"Hosfield DJ, Zhang Y, Dougan DR, Broun A, Tari LW, Swanson RV, Finn J: Structural basis for bisphosphonate-mediated inhibition of isoprenoid biosynthesis. J Biol Chem. 2004, 279: 8526-8529. 10.1074\/jbc.C300511200.","journal-title":"J Biol Chem"},{"key":"1809_CR14","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1359\/jbmr.1997.12.9.1358","volume":"12","author":"JC Frith","year":"1997","unstructured":"Frith JC, Monkkonen J, Blackburn GM, Russell RG, Rogers MJ: Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5'-(beta, gamma-dichloromethylene) triphosphate, by mammalian cells in vitro. J Bone Miner Res. 1997, 12: 1358-1367. 10.1359\/jbmr.1997.12.9.1358.","journal-title":"J Bone Miner Res"},{"key":"1809_CR15","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s00223-004-0024-1","volume":"75","author":"MJ Rogers","year":"2004","unstructured":"Rogers MJ: From molds and macrophages to mevalonate: a decade of progress in understanding the molecular mode of action of bisphosphonates. Calcif Tissue Int. 2004, 75: 451-461. 10.1007\/s00223-004-0024-1.","journal-title":"Calcif Tissue Int"},{"key":"1809_CR16","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1023\/A:1014418017382","volume":"71","author":"GG Reinholz","year":"2002","unstructured":"Reinholz GG, Getz B, Sanders ES, Karpeisky MY, Padyukova N, Mikhailov SN, Ingle JN, Spelsberg TC: Distinct mechanisms of bisphosphonate action between osteoblasts and breast cancer cells: identity of a potent new bisphosphonate analogue. Breast Cancer Res Treat. 2002, 71: 257-268. 10.1023\/A:1014418017382.","journal-title":"Breast Cancer Res Treat"},{"key":"1809_CR17","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1172\/JCI115539","volume":"88","author":"M Sato","year":"1991","unstructured":"Sato M, Grasser W, Endo N, Akins R, Simmons H, Thompson DD, Golub E, Rodan GA: Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure. J Clin Invest. 1991, 88: 2095-2105. 10.1172\/JCI115539.","journal-title":"J Clin Invest"},{"key":"1809_CR18","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S0955-0674(00)00228-3","volume":"13","author":"SP Yu","year":"2001","unstructured":"Yu SP, Canzoniero LM, Choi DW: Ion homeostasis and apoptosis. Curr Opin Cell Biol. 2001, 13: 405-411. 10.1016\/S0955-0674(00)00228-3.","journal-title":"Curr Opin Cell Biol"},{"key":"1809_CR19","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/0014-4827(88)90191-7","volume":"175","author":"IA Silver","year":"1988","unstructured":"Silver IA, Murrills RJ, Etherington DJ: Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts. Exp Cell Res. 1988, 175: 266-276. 10.1016\/0014-4827(88)90191-7.","journal-title":"Exp Cell Res"},{"key":"1809_CR20","doi-asserted-by":"publisher","first-page":"6258s","DOI":"10.1158\/1078-0432.CCR-06-0840","volume":"12","author":"JJ Body","year":"2006","unstructured":"Body JJ: Breast cancer: bisphosphonate therapy for metastatic bone disease. Clin Cancer Res. 2006, 12: 6258s-6263s. 10.1158\/1078-0432.CCR-06-0840.","journal-title":"Clin Cancer Res"},{"key":"1809_CR21","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/sj.bjc.6602181","volume":"91","author":"F Journe","year":"2004","unstructured":"Journe F, Chaboteaux C, Dumon JC, Leclercq G, Laurent G, Body JJ: Steroid-free medium discloses oestrogenic effects of the bisphosphonate clodronate on breast cancer cells. Br J Cancer. 2004, 91: 1703-1710.","journal-title":"Br J Cancer"},{"key":"1809_CR22","doi-asserted-by":"publisher","first-page":"48213","DOI":"10.1074\/jbc.M106473200","volume":"276","author":"FP Coxon","year":"2001","unstructured":"Coxon FP, Helfrich MH, Larijani B, Muzylak M, Dunford JE, Marshall D, McKinnon AD, Nesbitt SA, Horton MA, Seabra MC, Ebetino FH, Rogers MJ: Identification of a novel phosphonocarboxylate inhibitor of Rab geranylgeranyl transferase that specifically prevents Rab prenylation in osteoclasts and macrophages. J Biol Chem. 2001, 276: 48213-48222.","journal-title":"J Biol Chem"},{"key":"1809_CR23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ejphar.2006.11.064","volume":"559","author":"MA Merrell","year":"2007","unstructured":"Merrell MA, Wakchoure S, Ilvesaro JM, Zinn K, Gehrs B, Lehenkari PP, Harris KW, Selander KS: Differential effects of Ca2+ on bisphosphonate-induced growth inhibition in breast cancer and mesothelioma cells. Eur J Pharmacol. 2007, 559: 21-31. 10.1016\/j.ejphar.2006.11.064.","journal-title":"Eur J Pharmacol"},{"key":"1809_CR24","doi-asserted-by":"publisher","first-page":"6222s","DOI":"10.1158\/1078-0432.CCR-06-0843","volume":"12","author":"AJ Roelofs","year":"2006","unstructured":"Roelofs AJ, Thompson K, Gordon S, Rogers MJ: Molecular mechanisms of action of bisphosphonates: current status. Clin Cancer Res. 2006, 12: 6222s-6230s. 10.1158\/1078-0432.CCR-06-0843.","journal-title":"Clin Cancer Res"},{"key":"1809_CR25","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.jinorgbio.2006.01.005","volume":"100","author":"E Matczak-Jon","year":"2006","unstructured":"Matczak-Jon E, Kurzak B, Kafarski P, Wozna A: Coordination abilities of piperyd-1-yl-methane-1,1-diphosphonic acids towards zinc(II), magnesium(II) and calcium(II): potentiometric and NMR studies. J Inorg Biochem. 2006, 100: 1155-1166. 10.1016\/j.jinorgbio.2006.01.005.","journal-title":"J Inorg Biochem"},{"key":"1809_CR26","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3109\/10611869409015910","volume":"2","author":"J Monkkonen","year":"1994","unstructured":"Monkkonen J, Taskinen M, Auriola SO, Urtti A: Growth inhibition of macrophage-like and other cell types by liposome-encapsulated, calcium-bound, and free bisphosphonates in vitro. J Drug Target. 1994, 2: 299-308. 10.3109\/10611869409015910.","journal-title":"J Drug Target"},{"key":"1809_CR27","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1359\/jbmr.1999.14.5.784","volume":"14","author":"IM Twiss","year":"1999","unstructured":"Twiss IM, Pas O, Ramp-Koopmanschap W, Den Hartigh J, Vermeij P: The effects of nitrogen-containing bisphosphonates on human epithelial (Caco-2) cells, an in vitro model for intestinal epithelium. J Bone Miner Res. 1999, 14: 784-791. 10.1359\/jbmr.1999.14.5.784.","journal-title":"J Bone Miner Res"},{"key":"1809_CR28","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1359\/jbmr.2003.18.2.204","volume":"18","author":"JC Frith","year":"2003","unstructured":"Frith JC, Rogers MJ: Antagonistic effects of different classes of bisphosphonates in osteoclasts and macrophages in vitro. J Bone Miner Res. 2003, 18: 204-212. 10.1359\/jbmr.2003.18.2.204.","journal-title":"J Bone Miner Res"},{"key":"1809_CR29","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1023\/A:1026126430905","volume":"81","author":"M Merrell","year":"2003","unstructured":"Merrell M, Suarez-Cuervo C, Harris KW, Vaananen HK, Selander KS: Bisphosphonate induced growth inhibition of breast cancer cells is augmented by p38 inhibition. Breast Cancer Res Treat. 2003, 81: 231-241. 10.1023\/A:1026126430905.","journal-title":"Breast Cancer Res Treat"},{"key":"1809_CR30","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0277-5387(01)00996-2","volume":"21","author":"E Matczak-Jon","year":"2002","unstructured":"Matczak-Jon E, Kurzak B, Kamecka A, Kafarski P: Interactions of zinc(II), magnesium(II) and calcium(II) with aminomethane-1,1-diphosphonic acids in aqueous solutions. Polyhedron. 2002, 21: 321-332. 10.1016\/S0277-5387(01)00996-2.","journal-title":"Polyhedron"},{"key":"1809_CR31","doi-asserted-by":"publisher","first-page":"4357","DOI":"10.1210\/endo.141.12.7849","volume":"141","author":"JL Sanders","year":"2000","unstructured":"Sanders JL, Chattopadhyay N, Kifor O, Yamaguchi T, Butters RR, Brown EM: Extracellular calcium-sensing receptor expression and its potential role in regulating parathyroid hormone-related peptide secretion in human breast cancer cell lines. Endocrinology. 2000, 141: 4357-4364. 10.1210\/en.141.12.4357.","journal-title":"Endocrinology"},{"key":"1809_CR32","doi-asserted-by":"publisher","first-page":"10954","DOI":"10.1073\/pnas.1830978100","volume":"100","author":"JJ Yin","year":"2003","unstructured":"Yin JJ, Mohammad KS, Kakonen SM, Harris S, Wu-Wong JR, Wessale JL, Padley RJ, Garrett IR, Chirgwin JM, Guise TA: A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases. Proc Natl Acad Sci USA. 2003, 100: 10954-10959. 10.1073\/pnas.1830978100.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1809_CR33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0304-3835(97)00542-9","volume":"127","author":"M Lacroix","year":"1998","unstructured":"Lacroix M, Siwek B, Marie PJ, Body JJ: Production and regulation of interleukin-11 by breast cancer cells. Cancer letters. 1998, 127: 29-35. 10.1016\/S0304-3835(97)00542-9.","journal-title":"Cancer letters"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr1845.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/bcr1845\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr1845.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T11:06:25Z","timestamp":1728385585000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/bcr1845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,11]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2008,2]]}},"alternative-id":["1809"],"URL":"https:\/\/doi.org\/10.1186\/bcr1845","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,11]]},"assertion":[{"value":"13 June 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2008","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2008","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R4"}}